Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the treatment of children with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS) IV pilot study.
Arndt C, Tefft M, Gehan E, Anderson J, Jenson M, Link M, Donaldson S, Breneman J, Wiener E, Webber B, Maurer H. Arndt C, et al. Among authors: gehan e. J Pediatr Hematol Oncol. 1997 Mar-Apr;19(2):124-9. doi: 10.1097/00043426-199703000-00005. J Pediatr Hematol Oncol. 1997. PMID: 9149741 Clinical Trial.
Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.
Raney RB, Meza J, Anderson JR, Fryer CJ, Donaldson SS, Breneman JC, Fitzgerald TJ, Gehan EA, Michalski JM, Ortega JA, Qualman SJ, Sandler E, Wharam MD, Wiener ES, Maurer HM, Crist WM. Raney RB, et al. Among authors: gehan ea. Med Pediatr Oncol. 2002 Jan;38(1):22-32. doi: 10.1002/mpo.1259. Med Pediatr Oncol. 2002. PMID: 11835233
Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma. A pilot study without hematopoietic growth factor support evaluating toxicity and response.
Ruymann FB, Vietti T, Gehan E, Wiener E, Wharam M, Newton WA Jr, Maurer H. Ruymann FB, et al. Among authors: gehan e. J Pediatr Hematol Oncol. 1995 Nov;17(4):331-7. doi: 10.1097/00043426-199511000-00009. J Pediatr Hematol Oncol. 1995. PMID: 7583389 Clinical Trial.
Secondary surgical procedures to evaluate primary tumor status in patients with chemotherapy-responsive stage III and IV sarcomas: a report from the Intergroup Rhabdomyosarcoma Study.
Hays DM, Raney RB, Crist WM, Lawrence WW Jr, Ragab A, Wharam MD, Webber B, Gehan E, Johnston J, Maurer HM. Hays DM, et al. Among authors: gehan e. J Pediatr Surg. 1990 Oct;25(10):1100-5. doi: 10.1016/0022-3468(90)90228-2. J Pediatr Surg. 1990. PMID: 2262867 Clinical Trial.
Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites. A report from the Intergroup Rhabdomyosarcoma Study.
Raney RB Jr, Tefft M, Newton WA, Ragab AH, Lawrence W Jr, Gehan EA, Maurer HM. Raney RB Jr, et al. Among authors: gehan ea. Cancer. 1987 Jan 1;59(1):147-55. doi: 10.1002/1097-0142(19870101)59:1<147::aid-cncr2820590129>3.0.co;2-8. Cancer. 1987. PMID: 3791141 Clinical Trial.
Rhabdomyosarcoma of the female urogenital tract.
Hays DM, Raney RB Jr, Lawrence W Jr, Gehan EA, Soule EH, Tefft M, Maurer HM. Hays DM, et al. Among authors: gehan ea. J Pediatr Surg. 1981 Dec;16(6):828-34. doi: 10.1016/s0022-3468(81)80828-7. J Pediatr Surg. 1981. PMID: 7338762
The Third Intergroup Rhabdomyosarcoma Study.
Crist W, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J, Heyn R, et al. Crist W, et al. Among authors: gehan ea. J Clin Oncol. 1995 Mar;13(3):610-30. doi: 10.1200/JCO.1995.13.3.610. J Clin Oncol. 1995. PMID: 7884423 Clinical Trial.
220 results